Experienced in Factor 11 Deficiency

Dr. Michael A. Boxer

Hematology Oncology
603 N Wilmot Rd Ste 151, 
Tucson, AZ 
Experienced in Factor 11 Deficiency
603 N Wilmot Rd Ste 151, 
Tucson, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Boxer is a Hematologist Oncology provider in Tucson, Arizona. Dr. Boxer is rated as an Experienced provider by MediFind in the treatment of Factor 11 Deficiency. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Myelodysplastic Syndrome (MDS), Sideroblastic Anemia, and Myeloproliferative Neoplasms (MPN).

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in AZ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

603 N Wilmot Rd Ste 151, Tucson, AZ 85711

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: October 31, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Enrollment Status: Completed
Publish Date: July 21, 2021
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 2
View 3 Less Clinical Trials

14 Total Publications

Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Journal: American journal of hematology
Published: October 06, 2021
Similar Doctors
Advanced in Factor 11 Deficiency
Dr. Catherine A. Azar
Hematology Oncology | Hematology | Oncology
Advanced in Factor 11 Deficiency
Dr. Catherine A. Azar
Hematology Oncology | Hematology | Oncology

Arizona Blood And Cancer Specialists, PLLC

3945 E Paradise Falls Dr, Suite 105, 
Tucson, AZ 
 (4.1 miles away)
520-689-7030
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Catherine Azar is a Hematologist Oncology specialist and a Hematologist in Tucson, Arizona. Dr. Azar is rated as a Distinguished provider by MediFind in the treatment of Factor 11 Deficiency. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Azar is currently accepting new patients.

Experienced in Factor 11 Deficiency
Dr. Aung Bajaj
Hematology Oncology
Experienced in Factor 11 Deficiency
Dr. Aung Bajaj
Hematology Oncology

Arizona Oncology Associates PC

603 N Wilmot Rd, Suite 151, 
Tucson, AZ 
 (1.8 miles away)
520-886-0206
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Aung Bajaj is a Hematologist Oncology provider in Tucson, Arizona. Dr. Bajaj is rated as an Advanced provider by MediFind in the treatment of Factor 11 Deficiency. His top areas of expertise are Hemochromatosis, Chronic Familial Neutropenia, Agranulocytosis, and Prostate Cancer.

Experienced in Factor 11 Deficiency
Dr. Ravitharan Krishnadasan
Hematology Oncology | Hematology | Oncology
Experienced in Factor 11 Deficiency
Dr. Ravitharan Krishnadasan
Hematology Oncology | Hematology | Oncology

Banner-University Medical Group

535 N Wilmot Rd, Suite 101, 
Tucson, AZ 
 (1.7 miles away)
520-694-5437
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ravitharan Krishnadasan is a Hematologist Oncology specialist and a Hematologist in Tucson, Arizona. Dr. Krishnadasan is rated as a Distinguished provider by MediFind in the treatment of Factor 11 Deficiency. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Krishnadasan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boxer's expertise for a condition
ConditionClose
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile